ArticleDer Unfallchirurg2021
[Bone transplantation or biomaterials? : An analysis of 99,863 surgical procedures in orthopedic and trauma surgery in Germany from 2018].
Article in Der Unfallchirurg, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Fiberfill©-A New Bone Substitute for Treatment of Chronic Osteomyelitis?Journal of clinical medicine · 2026Article
- [Treatment of bony defects in femur and tibia : Established and new concepts].Unfallchirurgie (Heidelberg, Germany) · 2025Article
- [Isolated osseous tuberculosis : Differential diagnosis of treatment refractory osteomyelitis?]Unfallchirurgie (Heidelberg, Germany) · 2025Article
- Hydrogel Use in Osteonecrosis of the Femoral Head.Gels (Basel, Switzerland) · 2024Review
- Injectable Photo-Crosslinked Bioactive BMSCs-BMP2-GelMA Scaffolds for Bone Defect Repair.Frontiers in bioengineering and biotechnology · 2022Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aims of this study were (1) to analyze the total number of interventions with autologous or allogeneic bone transplantation as well as biomaterials, (2) to investigate the different types of biomaterials, autologous and allogeneic bone transplantations and (3) to analyze the additional use of an antibiotic additive in biomaterials.
methodsData were obtained from the Federal Statistical Office for the year 2018. The surgery and procedure codes 5‑784 "bone transplantation and transposition" and 5‑785 "implantation of alloplastic bone substitutes" were used to analyze the procedure frequency of implantation of biomaterials, such as calcium phosphate ceramics, calcium sulphate, calcium phosphate cements and polymethyl methacrylate as well as autologous and allogeneic bone for defect reconstruction of the extremities and pelvis.
resultsIn 2018 a total of 99,863 procedures were performed using autografts (54,784, 55%), biomaterials (23,838, 24%) and allografts (21,241, 21%). For both autografts and allografts cancellous bone grafting was used most frequently (77% and 79%, respectively). For biomaterials, ceramics (42%) were used more frequently than bone cements (37%, other biomaterials 21%). In 16,027 cases (67%) with biomaterials no antibiotic supplement was used. Antibiotic supplementation was mainly used for bone cements (6612 cases, 75%).
conclusionIn 2018 bone transplants or biomaterials were used in a considerable number of the 99,863 bone defect reconstruction procedures. Autologous bone was used in more than half of the cases (55%), biomaterials in approximately one quarter (24%) and allogenic bone in approximately one fifth (21%). Ceramics (42%) were more often used as biomaterials than cements (37%). The addition of antibiotics was mainly used with cements (75%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.